Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study

被引：0

作者：

Inmaculada López Montesinos

Silvia Gómez-Zorrilla

Zaira Raquel Palacios-Baena

Nuria Prim

Daniel Echeverria-Esnal

María Pilar Gracia

María Milagro Montero

Xavier Durán-Jordà

Elena Sendra

Luisa Sorli

Roberto Guerri-Fernandez

Eduardo Padilla

Santiago Grau

Juan Pablo Horcajada

机构：

[1] Hospital del Mar,Infectious Diseases Service

[2] Infectious Pathology and Antimicrobials Research Group (IPAR),Unit of Infectious Diseases and Clinical Microbiology. Institute of Biomedicine of Seville (IBIS)

[3] Institut Hospital del Mar d’Investigacions Mèdiques (IMIM),Microbiology Service

[4] Universitat Pompeu Fabra (UPF),Pharmacy Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)

[5] Spanish Network for Research in Infectious Diseases (REIPI),Intensive Care Unit Service, Hospital del Mar, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)

[6] University Hospital Virgen Macarena,Methodology and Biostatistics Support Unit

[7] Laboratori de Referència de Catalunya,undefined

[8] Universitat Pompeu Fabra (UPF),undefined

[9] Universitat Pompeu Fabra (UPF),undefined

[10] Institut Hospital del Mar d’Investigacions Mèdiques (IMIM),undefined

来源：

Infectious Diseases and Therapy | 2022年 / 11卷

关键词：

Extensively drug-resistant ; Urinary tract infections; Amikacin; Colistin; Antimicrobial stewardship;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：335 / 350

页数：15

共 33 条

[21] Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam
Rodriguez-Nunez, Olga
Perianez-Parraga, Leonor
Oliver, Antonio
Munita, Jose M.
Bote, Anna
Gasch, Oriol
Nuvials, Xavier
Dinh, Aurelien
Shaw, Robert
Lomas, Jose M.
Torres, Vicente
Caston, Juanjo
Araos, Rafael
Abbo, Lilian M.
Rakita, Robert
Perez, Federico
Aitken, Samuel L.
Arias, Cesar A.
Luisa Martin-Pena, M.
Colomar, Asun
Belen Nunez, M.
Mensa, Josep
Antonio Martinez, Jose
Soriano, Alex
OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (10):
[22] Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study
Alkabbani, Wajd
Zongo, Arsene
Minhas-Sandhu, Jasjeet K.
Eurich, Dean T.
Shah, Baiju R.
Alsabbagh, Mhd Wasem
Gamble, John-Michael
CANADIAN JOURNAL OF DIABETES, 2022, 46 (04) : 392 - +
[23] High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumanni: An Observational Cohort Study
Han, Hui
Qin, Weidong
Zheng, Yue
Cao, Dongming
Lu, Haining
Zhang, Lu
Cui, Yi
Hu, Yuanyuan
Li, Wei
Guo, Haipeng
Wu, Dawei
Li, Chen
Wang, Hao
Chen, Yuguo
INFECTION AND DRUG RESISTANCE, 2021, 14 : 3837 - 3848
[24] Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15)
Pfaller, Michael A.
Bassetti, Matteo
Duncan, Leonard R.
Castanheira, Mariana
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (05) : 1386 - 1395
[25] Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study
Gomez-Junyent, Joan
Rigo-Bonnin, Raul
Benavent, Eva
Soldevila, Laura
Padulles, Ariadna
Cabo, Xavier
Tubau, Fe
Ariza, Javier
Murillo, Oscar
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (05) : 587 - 599
[26] Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study
Joan Gómez-Junyent
Raul Rigo-Bonnin
Eva Benavent
Laura Soldevila
Ariadna Padullés
Xavier Cabo
Fe Tubau
Javier Ariza
Oscar Murillo
European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 587 - 599
[27] Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Carmeli, Yehuda
Armstrong, Jon
Laud, Peter J.
Newell, Paul
Stone, Greg
Wardman, Angela
Gasink, Leanne B.
LANCET INFECTIOUS DISEASES, 2016, 16 (06): : 661 - 673
[28] In-Depth Study of a Nosocomial Outbreak Caused by Extensively Drug-Resistant Pseudomonas aeruginosa Using Whole Genome Sequencing Coupled With a Polymerase Chain Reaction Targeting Strain-Specific Single Nucleotide Polymorphisms
Acosta, Fermin
Fernandez-Cruz, Ana
Maus, Sandra R.
Sola-Campoy, Pedro J.
Marin, Mercedes
Cercenado, Emilia
Sierra, Olalla
Munoz, Patricia
Garcia de Viedma, Dario
Perez-Lago, Laura
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2020, 189 (08) : 841 - 849
[29] Magnetic resonance-guided laser interstitial thermal therapy vs. open surgery for drug-resistant mesial temporal lobe epilepsy: a propensity score matched retrospective cohort study
Mo, Jiajie
Guo, Zhihao
Wang, Xiu
Zhang, Jianguo
Hu, Wenhan
Shao, Xiaoqiu
Sang, Lin
Zheng, Zhong
Zhang, Chao
Zhang, Kai
INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (01) : 306 - 314
[30] Efficacy and safety of polymyxin B sulfate versus colistin sulfate in ICU patients with nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii: a multicenter, propensity score-matched, real-world cohort study
Bu, Wei
Wang, Chengyu
Wu, Yuan
Zhang, Peng
Zhang, Nengfang
Han, Ying
Xu, Xiaona
Li, Sha
Cai, Yan
BMC INFECTIOUS DISEASES, 2025, 25 (01)

← 1 2 3 4 →